Boehringer Ingelheim Animal Health announced the recipients of the 2024 Advancement in Equine Research Awards during the 70th annual American Association of Equine Practitioners Convention, held in Orlando, Florida, from Dec. 7-11. The recipients were chosen based on their research proposals which included subject matter focused on equine infectious disease.
Recipients are the following:
- Serena Ceriotti DVM, MS, PhD, DACVIM-LA, Auburn University College of Veterinary Medicine, Auburn, Alabama
- Nicola Pusterla DVM, PhD, DACVIM, AVDC-Equine, School of Veterinary Medicine, University of California, Davis, California
- Smriti Shringi B.V.Sc & A.H., DVM, M.V.Sc., MS, PhD, School of Veterinary Medicine, Texas Tech University, Amarillo, Texas
- Hossam Elsayed BVSc/DVM (VD and Hons), MVSc, PhD, PhD, Diplomate ACT, Gluck Equine Research Center, University of Kentucky, Lexington, Kentucky
“At Boehringer Ingelheim, we acknowledge that the health and well-being of animals is pivotal to the success of moving life forward for humans and animals. Our dedication and passion for the advancement of equine research makes Boehringer a global leader in its field,” said Steve Grubbs, DVM, PhD, DACVIM, equine technical manager for Boehringer. “Previous award recipients have made significant contributions to the advancement of research in equine infectious disease, and we anticipate this year’s recipients will follow suit.”
Those eligible to submit proposals were veterinarians, diagnosticians, and public and private researchers in the United States, Canada, and Mexico.
The Boehringer Advancement in Equine Research Awards program was launched in 2011 to support veterinary research that results in practical applications for insights into important equine infectious and non-infectious diseases. Nearly $900,000 has been awarded to date for emerging science in equine research.
To learn more about Boehringer Ingelheim equine, click here.
About Boehringer Ingelheim
Boehringer Ingelheim provides innovation for preventing and treating diseases in animals. The company offers a wide range of vaccines, parasite-control products, and medicines for pets, horses, and livestock to veterinarians, animal owners, farmers, and governments. As a leader in animal health, Boehringer Ingelheim values that the health of humans and animals is deeply connected and strives to make a difference for people, animals, and society. Learn more at www.bi-animalhealth.com.
